- United Arab Emirates
- /
- Insurance
- /
- ADX:EIC
Emirates Insurance Company P.J.S.C Second Quarter 2025 Earnings: EPS: د.إ0.24 (vs د.إ0.077 in 2Q 2024)
Emirates Insurance Company P.J.S.C (ADX:EIC) Second Quarter 2025 Results
Key Financial Results
- Revenue: د.إ169.4m (up 28% from 2Q 2024).
- Net income: د.إ35.3m (up 204% from 2Q 2024).
- Profit margin: 21% (up from 8.7% in 2Q 2024). The increase in margin was driven by higher revenue.
- EPS: د.إ0.24 (up from د.إ0.077 in 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Emirates Insurance Company P.J.S.C's share price is broadly unchanged from a week ago.
Risk Analysis
Before we wrap up, we've discovered 1 warning sign for Emirates Insurance Company P.J.S.C that you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if Emirates Insurance Company P.J.S.C might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ADX:EIC
Emirates Insurance Company P.J.S.C
Engages in writing general insurance and reinsurance in the United Arab Emirates, the United States, and Europe.
Flawless balance sheet 6 star dividend payer.
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Adobe: A Probabilistic Case for Undervaluation

A Capital Allocation Favorite with Structural Importance

Good foundation, but now it's all about the next steps
Recently Updated Narratives

Adobe: A Probabilistic Case for Undervaluation

Discounted Exit Multiple Approach (DEM)
Intel Story
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

